Home›Pediatrics› Short-course antibiotics cut complication risk by half in pediatric osteoarticular infections
Short-course antibiotics cut complication risk by half in pediatric osteoarticular infectionsShort Antibiotic Courses May Lower Risks for Children with Bone Infections
European journal of pediatricsPublished July 17, 2026Study authors: Berikopoulou Maria Maroudia, Konstantopoulou Argyro, Dimopoulou Konstantina, Tsoliakos Ioannis, Psal…PubMed ↗DOI ↗Editorial oversight: Dr. Sofia Müller, MD · Lifespan & Whole-Person Care
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider short-course antibiotics for uncomplicated pediatric osteoarticular infections to reduce complication risk.
This meta-analysis evaluated the efficacy of short-course versus long-course antimicrobial treatment in pediatric patients (up to 19 years old) with uncomplicated osteoarticular infections. The analysis included 2240 children from multiple studies.
The primary outcome was risk of complications. Short-course therapy was associated with a lower risk of complications compared to long-course therapy (random-effects RR 0.50, 95% CI 0.28-0.89; fixed-effects RR 0.44, 95% CI 0.30-0.65; p=0.022). In a subgroup of 778 children with treatment duration less than 25 days, the risk reduction was even more pronounced (RR 0.20, 95% CI 0.06-0.61, p=0.016). Secondary outcomes included sequelae, but specific data were not reported.
The authors noted heterogeneity in treatment durations across studies as a limitation. Adverse events, serious adverse events, and discontinuations were not reported. The findings suggest that short-course antibiotic treatment may be as effective as longer regimens and associated with fewer sequelae in uncomplicated cases, potentially reducing hospitalization duration and healthcare costs, though this remains conjectural.
Clinicians should consider these results cautiously given the observational nature of the included studies and the lack of reported safety data. The association between shorter duration and lower complication risk warrants further prospective investigation.
How this fits prior evidence
This meta-analysis extends prior coverage on antibiotic risks by focusing on pediatric osteoarticular infections, where shorter courses appear beneficial. Previous findings highlighted antibiotic exposure associated with an 18.7% higher risk of gastrointestinal cancers and reduced gut microbial diversity with perinatal antibiotics. The current result contrasts with those harms, suggesting that in specific infections, shorter antibiotic duration may reduce complications. It also complements the emphasis on antimicrobial stewardship in oral healthcare by providing evidence for shorter regimens in bone and joint infections.
Researchers analyzed data from 2,240 children up to 19 years old who had uncomplicated osteoarticular infections. The study compared two different ways of treating these infections: a short-course antimicrobial treatment and a longer-course treatment.
The results showed that the shorter course was associated with a lower risk of complications overall. This finding was particularly notable in children under 25 days old, where the risk of complications was even lower for those on the shorter treatment plan.
While these findings suggest that shorter treatments can be effective and safer for certain cases, it is important to note that different studies used varying lengths of time for their treatments. Because this was a meta-analysis of existing data, the results show an association rather than a direct cause. Patients and parents should talk to their doctors to determine the best treatment plan based on specific medical needs.
What this means for you:
Short-course antibiotics may lead to fewer complications in children with uncomplicated bone infections.
Common questions
Is a shorter course of antibiotics safe for children with bone infections?
The study found that short-course antimicrobial treatment was associated with a lower risk of complications compared to long-course treatments in children up to 19 years old. This included a significant reduction in risks for infants under 25 days old. You should speak with a doctor to determine the safest duration for a specific child's condition.
Who specifically can benefit from shorter antibiotic treatments?
The findings apply to pediatric patients up to 19 years old who have uncomplicated osteoarticular infections. The data showed that these children, especially those under 25 days old, had lower risks of complications when treated with a shorter course of antibiotics.
How does short-course treatment compare to long-term treatment?
The analysis of 2,240 patients showed that the shorter course was associated with fewer complications than the longer course. While both methods are used, the shorter duration appeared more effective at reducing risks in uncomplicated cases for children.
UNLABELLED: Pediatric osteoarticular infections (OAIs) are a significant cause of morbidity and can lead to severe orthopedic complications and long-term sequelae, if not promptly treated. Recent evidence increasingly favors shorter antibiotic courses in children with rapid clinical improvement, without compromising therapeutic outcomes. This study aimed tο assess the effectiveness of shorter length of antibiotics compared to prolonged treatment in pediatric population with uncomplicated OAIs. A systematic search was conducted in PubMed, Scopus, Web of Science and ClinicalTrial.gov. Studies including patients up to 19 years old that compared short-course with long-course antimicrobial treatment were eligible for inclusion. Due to variability in treatment durations across studies, no universal cut-off was applied; however, a subgroup analysis using a 25-day threshold was performed. Data were pooled and analyzed using DerSimonian-Laird random-effects and Mantel-Haenszel fixed-effects models. Thirteen studies (2,240 patients) were included in the analysis. Shorter course of antibiotic treatment was associated with a significantly lower observed risk of complications compared to longer courses. The pooled relative risk (RR) for complications with short-course therapy was 0.50 (95% CI: 0.28-0.89, p = 0.022) using the random-effect model and 0.44 (95% CI: 0.30-0.65) using the fixed-effects model, with low heterogeneity (I = 26.2%, p = 0.18). In a subgroup analysis of studies with a total treatment duration < 25 days (5 studies, 778 children), short-course therapy was associated with a reduced risk of complications (RR = 0.20; 95% CI: 0.06-0.61; p = 0.016, I = 0%).
CONCLUSIONS: Short course antibiotic treatment for pediatric OAIs appears to be as effective as longer regimens and is associated with fewer sequelae in uncomplicated cases with clinical improvement. These findings could inspire more randomized studies and ultimately contribute to reducing hospitalization duration and healthcare costs.
WHAT IS KNOWN: • Guidelines for osteoarticular infections treatment require prompt and prolonged antibiotic therapy. • Evidence regarding the optimal duration of antibiotic therapy for pediatric acute osteoarticular infections remains limited.
WHAT IS NEW: • Short course antibiotic treatment for pediatric osteoarticular infections appears to be as effective as longer regimens and is associated with fewer sequelae in uncomplicated cases with clinical improvement. • Total treatment duration < 25 days is associated with a reduced risk of complications.
